These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
163 related items for PubMed ID: 1793298
1. [Importance of aminoglycoside antibiotics in modern therapy of infectious-inflammatory diseases]. Ukhin AV. Antibiot Khimioter; 1991 Nov; 36(11):42-7. PubMed ID: 1793298 [No Abstract] [Full Text] [Related]
2. Alternative dosing strategy for aminoglycosides: impact on efficacy, nephrotoxicity, and ototoxicity. Chan GL. DICP; 1989 Oct; 23(10):788-94. PubMed ID: 2683419 [Abstract] [Full Text] [Related]
5. [Aminoglycoside antibiotics--should they be administered in a single dose? Practical point of view]. Niemczyk S, Stopiński M. Pol Arch Med Wewn; 1998 Apr; 99(4):348-52. PubMed ID: 9760824 [No Abstract] [Full Text] [Related]
10. Side effects of aminoglycosides on the kidney, ear and balance in cystic fibrosis. Prayle A, Watson A, Fortnum H, Smyth A. Thorax; 2010 Jul; 65(7):654-8. PubMed ID: 20627927 [Abstract] [Full Text] [Related]
11. Aminoglycoside prescribing and surveillance in cystic fibrosis. Tan KH, Mulheran M, Knox AJ, Smyth AR. Am J Respir Crit Care Med; 2003 Mar 15; 167(6):819-23. PubMed ID: 12623858 [No Abstract] [Full Text] [Related]
12. Role of aminoglycoside antibiotics in the treatment of intra-abdominal infection. Ho JL, Barza M. Antimicrob Agents Chemother; 1987 Apr 15; 31(4):485-91. PubMed ID: 3300527 [No Abstract] [Full Text] [Related]
14. Aminoglycoside antibiotic agents: a review. Spelman DW, McDonald M, Spicer WJ. Med J Aust; 1989 Sep 18; 151(6):346-9. PubMed ID: 2687667 [No Abstract] [Full Text] [Related]
15. [Value of aminoglycoside antibiotics in the therapy of bacterial infections]. Ade N, Hof H. Med Klin (Munich); 1993 Jul 15; 88(7):438-44. PubMed ID: 8377722 [No Abstract] [Full Text] [Related]
16. [Aminoglycosides are effective--but oto- and nephrotoxic. Knowledge base from the reference group for antibiotic issues on benefit-risk with aminoglycosides]. Ternhag A, Giske CG, Hanberger H. Lakartidningen; 1993 Jul 15; 111(7):268-9. PubMed ID: 24669487 [No Abstract] [Full Text] [Related]
17. [The clinical and pharmacodynamic aspects of the antibiotic therapy of infectious patients]. Lobzin IuV, Finogeev IuP, Vinakmen IuA, Zakharenko SM. Voen Med Zh; 2000 Mar 15; 321(3):46-51. PubMed ID: 10815542 [No Abstract] [Full Text] [Related]
18. Considerations regarding clinical safety and tolerability of antibiotics in serious and nosocomial infections. Smith CR. Clin Ther; 1981 Mar 15; 4 Suppl A():133-45. PubMed ID: 7034939 [Abstract] [Full Text] [Related]
19. [Amoxycillin/potassium clavulanate (augmentin)--current importance in the treatment of infection]. Fomina IP. Antibiot Khimioter; 1997 Mar 15; 42(9):36-43. PubMed ID: 9412419 [No Abstract] [Full Text] [Related]
20. [Therapeutic usefulness of aminoglycosides. Why netilmicin?]. Bossa R. Clin Ter; 1985 Nov 15; 115(3):201-4. PubMed ID: 4085177 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]